Ascendis Pharma A/S Ordinary Share (ASND) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Ascendis Pharma A/S Ordinary Share, updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$249.55
+1.50% today
Market cap
$16.2B
Overall quality
75/100
Kronos AI 30-day
+0.2%
4 of 8 simulated paths end higher
Ascendis Pharma A/S Ordinary Share (ASND) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $16.2B. It trades at $249.55, up 1.50% today, at 19.9 times earnings. Its overall quality score is 75 out of 100, ranked against the whole US market. Kronos AI's 30-day forecast is +0.2% (4 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
No analyst covers this listing yet.
Kronos AI 30-day forecast
| Expected close | $246.24 (+0.2%) |
| Likely range | −6.5% … +6.1% |
| As of | 2026-10-27 |
4 of 8 simulated paths end higher.
Quality scores
| Profitability | 81 |
| Solvency | 55 |
| Growth | 88 |
| Overall | 75 |
| P/E | 19.9 |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.